Watch CME. Know when insiders buy.
One email the day a filing lands. Free.
CME
CME GROUP INC.
295.31
+1.78 +0.61%
USD · close Oct 20
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
31
FLAG · insiders 30, shorts 31
Insiders, 90 days
−$4.2M
net selling · 1 buy, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
5 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $19.7BP/E 25.0DIV YIELD 3.81%FCF YIELD 21.41%REV TTM $6.8B +5.1%NET INCOME $4.3B +13.8%NET CASH —52W 218.58 – 326.46SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.7B | +0.8% | — | $1.1B | $1B | +1.6% | 2.88 | $947.1M | $23.6M | $923.5M | Jul 24 |
| Q1 2026 · Mar 31 | $1.9B | +14.5% | — | $1.3B | $1.2B | +20.7% | 3.18 | $1.3B | $21.8M | $1.2B | Apr 24 |
| Q4 2025 · Dec 31derived | $1.6B | +8.1% | — | $1B | $1.2B | +35.3% | 3.24 | $1.1B | $32.5M | $1.1B | Feb 26 |
| Q3 2025 · Sep 30 | $1.5B | −3.0% | — | $972.6M | $908M | −0.5% | 2.49 | $968.1M | $18.4M | $949.7M | Oct 24 |
| Q2 2025 · Jun 30 | $1.7B | +10.4% | — | $1.1B | $1B | +16.1% | 2.81 | $1.1B | $18.4M | $1B | Jul 24 |
| Q1 2025 · Mar 31 | $1.6B | +10.4% | — | $1.1B | $956.2M | +11.8% | 2.62 | $1.1B | $14.2M | $1.1B | Apr 24 |
| Q4 2024 · Dec 31derived | $1.5B | +6.0% | — | $947.1M | $874.6M | +7.4% | 2.40 | $1B | $26.2M | $991.7M | Feb 26 |
| Q3 2024 · Sep 30 | $1.6B | +18.4% | — | $1B | $912.8M | +21.7% | 2.50 | $1B | $29.8M | $973.2M | Oct 24 |
| Q2 2024 · Jun 30 | $1.5B | — | — | $1B | $883.2M | — | 2.42 | $776.9M | $18.2M | $758.7M | Jul 25 |
| Q1 2024 · Mar 31 | $1.5B | — | — | $959.6M | $855.2M | — | 2.35 | $892.7M | $19.8M | $872.9M | Apr 30 |
| Q4 2023 · Dec 31derived | $1.4B | — | — | $863.2M | $814.4M | — | 2.24 | $1B | $20.8M | $1B | Feb 26 |
| Q3 2023 · Sep 30 | $1.3B | — | — | $820.2M | $750.2M | — | 2.06 | $856.7M | $19.9M | $836.8M | Nov 8 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $6.5B | — | $4.2B | $4.1B | 62.5% | 11.16 | $4.3B | $83.5M | $4.2B | — | $3.9B |
| FY2024 · to Dec 31 | $6.1B | — | $3.9B | $3.5B | 57.5% | 9.67 | $3.7B | $94M | $3.6B | — | $3.6B |
| FY2023 · to Dec 31 | $5.6B | — | $3.4B | $3.2B | 57.8% | 8.86 | $3.5B | $76.4M | $3.4B | — | $3.2B |
| FY2022 · to Dec 31 | $5B | — | $3B | $2.7B | 53.6% | 7.40 | $3.1B | $89.7M | $3B | — | $2.6B |
| FY2021 · to Dec 31 | $4.7B | — | $2.6B | $2.6B | 56.2% | 7.29 | $2.4B | $127.2M | $2.3B | — | $2.2B |
| FY2020 · to Dec 31 | $4.9B | — | $2.6B | $2.1B | 43.1% | 5.87 | $2.7B | $197.5M | $2.5B | — | $2.1B |
Every number comes from CME GROUP INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.